Home Archive Acetaminophen Recall Warning Emails

Acetaminophen Recall Warning Emails

by Brett M. Christensen

A number of emails are circulating that warn consumers that certain batches of Acetaminophen 500mg caplets are being recalled because some of the caplets may contain metal fragments that could cause illness or injuries(Full commentary below).


Subject: Acetaminophen recall

I checked, this is true…please send this to everyone!

The U.S. Food and Drug Administration (FDA) is alerting the public to a voluntary recall being conducted by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various store-brands as a result of small metal fragments found in a small number of these caplets. Approximately 11 million bottles containing varying quantities of acetaminophen 500mg caplets are affected by this recall. For a list of batches affected….

[Full text of message quotes an FDA news release ]

Detailed Analysis:
In November 2006 I began receiving submissions regarding warning emails that claim batches of acetaminophen (paracetamol) have been recalled after metal fragments were discovered in some caplets. The warning emails quote from a U.S. Food and Drug Administration (FDA) News Release and other news reports about the recall.

The information in these email warnings is true. The Perrigo Company is conducting a voluntary recall of 383 batches of acetaminophen 500mg caplets. The FDA has published a list of affected batches so that consumers can check any acetaminophen they may already have by locating the container’s batch number. They have also published a list of stores that carry store-brands potentially affected by the recall.

The FDA stresses that there has been no reported injuries so far. Nor does it expect the contamination to result in serious injury or illness. According to the FDA News Release:

To date, there have been no illness or injuries received related to this problem and no consumer complaints have been reported to the FDA or to Perrigo. Based on information currently available, the FDA believes the probability of serious adverse health consequences is remote; however if a consumer were to swallow an affected caplet, it could result in minor stomach discomfort and/or possible cuts to the mouth or throat. Consumers should consult their physician if they suspect they’ve been harmed by use of this product.

Consumers who believe they are in possession of the affected products should discontinue use immediately and call Perrigo’s Consumer Affairs Department, 877-546-0454 for further instructions. Any adverse reactions experienced with the use of this product should be reported to Perrigo at the above number and the FDA’s MedWatch Program by phone at 800-FDA-1088, by fax at 800-FDA-0178 or on the MedWatch website at www.fda.gov/medwatch.

Email can be a useful method of rapidly spreading information about potential health risks of this nature. However, there are also potential problems with forwarding such emails. Warning emails are likely to continue circulating long after the described risk has been eliminated. They also tend to be continually modified as they circulate and factual content can become mixed with half-truths and misinformation.

In 2000, a warning email advising of a recall of products containing phenylpropanolamine (PPA) began to circulate. The information in the warning message was factual at that time. The message contained a long list of products that contained PPA. Unfortunately, versions of the message continue to circulate several years later, even though manufacturers have almost certainly removed all Phenylpropanolamine from the listed products years ago. Moreover, mutated versions of the message have emerged. One version castigates the Australia government for not following the lead of the FDA by controlling the substance. In fact, measures were taken to limit the availability of products containing PPA in Australia as far back as 1983. Australia’s Therapeutic Goods Administration notes that all remaining products containing PPA were withdrawn by July 2001.

Thus it is important to check the status of any recall warning emails before you forward them. The websites of government agencies such as the FDA and Therapeutic Goods Administration will generally publish up-to-date information about product recalls. Forwarding outdated or misleading recall warning emails is counterproductive and will only cause confusion and clutter inboxes.

Last updated: ADD
First published: ADD
By Brett M. Christensen
About Hoax-Slayer

FDA Informs Public of Nationwide Recall of 500mg Strength Store-Brand Acetaminophen Caplets
Perrigo – voluntary recall
Perrigo Voluntary Product Recall Acetaminophen 500mg Pain Reliever Caplets —Recalled Batches
Perrigo Voluntary Product Recall Customer List – Acetaminophen 500 mg Pain Reliever
Phenylpropanolamine FDA Recall Warning Email
TGA: Phenylpropanolamine

Importance Notice

After considerable thought and with an ache in my heart, I have decided that the time has come to close down the Hoax-Slayer website.

These days, the site does not generate enough revenue to cover expenses, and I do not have the financial resources to sustain it going forward.

Moreover, I now work long hours in a full-time and physically taxing job, so maintaining and managing the website and publishing new material has become difficult for me.

And finally, after 18 years of writing about scams and hoaxes, I feel that it is time for me to take my fingers off the keyboard and focus on other projects and pastimes.

When I first started Hoax-Slayer, I never dreamed that I would still be working on the project all these years later or that it would become such an important part of my life. It's been a fantastic and engaging experience and one that I will always treasure.

I hope that my work over the years has helped to make the Internet a little safer and thwarted the activities of at least a few scammers and malicious pranksters.

A Big Thank You

I would also like to thank all of those wonderful people who have supported the project by sharing information from the site, contributing examples of scams and hoaxes, offering suggestions, donating funds, or helping behind the scenes.

I would especially like to thank David White for his tireless contribution to the Hoax-Slayer Facebook Page over many years. David's support has been invaluable, and I can not thank him enough.

Closing Date

Hoax-Slayer will still be around for a few weeks while I wind things down. The site will go offline on May 31, 2021. While I will not be publishing any new posts, you can still access existing material on the site until the date of closure.

Thank you, one and all!

Brett Christensen,